NSRX

Nasus Pharma Ltd.

4.00 USD

Last updated Sep 12, 01:17 UTC

Yesterday HIGH

$3.48

Yesterday LOW

$3.3

52w HIGH

$9.5

52w LOW

$1.98

EPS

-0.54

PE

-7.41

Next Earnings

Feb 15, 2027

Overview News Government Trades Fundamentals

Nasus Pharma Ltd. stock is up 23.46% since 30 days ago. The next earnings date is Feb 15, 2027. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 September’s closed higher than August.

Benzinga Newsdesk

Wed Aug 19, 2026

Nasus Pharma Announces CFO Eyal Rubin To Depart September 18; Appoints Oren Elmaliach As Interim CFO
Benzinga Newsdesk

Mon Aug 17, 2026

Nasus Pharma H1 EPS $(0.54) Misses $(0.20) Estimate

Nasus Pharma (AMEX:NSRX) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.20) by 170 percent. This is a 217.65 percent decrease over losses of $(0.17) per share from the
Benzinga Newsdesk

Tue Jul 28, 2026

Nasus Pharma Appoints Brendan O'Grady As CEO, Succeeding Dan Teleman, Effective July 27

Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus", "Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced the
Benzinga Newsdesk

Tue Jun 9, 2026

Nasus Pharma Announces NS003 Trial Demonstrates Preclinical Pharmacokinetic Profile Comparable To IV

Nasus Pharma Ltd. (NYSE:NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced positive results from a
Benzinga Insights

Wed Apr 22, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Fri Apr 10, 2026

12 Health Care Stocks Moving In Friday's After-Market Session